Author

J. E. C. Hallak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:behavioral assay· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Campos· 1 shared A. L. C. Darini· 1 shared A. W. Zuardi· 1 shared C. A. Sorgi· 1 shared C. M. Ribeiro· 1 shared E. J. Fusse· 1 shared F. Bellissimo-Rodrigues· 1 shared F. d. L. Moreira· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. C. Campos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex.

F. F. Scarante, V. D. Lopes, E. J. Fusse, M. A. Vicente, G. H. D. de Abreu, C. A. Sorgi, V. Nardini, P. H. C. Lirio, F. Gou, H.-C. Liu, J. E. C. Hallak, J. A. S. Crippa, L. H. Faccioli, K. U. Sales, F. S. Guimaraes, , A. C. Campos

This study shows that CBD reduces the latency of escitalopram's anti-stress effects in chronically stressed mice, involving NAPE-PLD in the prefrontal cortex and parvalbumin interneurons.

bioRxiv · Apr 23, 2021Pharmacology & Toxicology

Cannabidiol (CBD) repurposing as antibacterial: promising therapy of CBD plus polymyxin B against superbugs

N. Abichabki, L. V. Zacharias, N. C. Moreira, F. Bellissimo-Rodrigues, F. d. L. Moreira, J. R. d. L. Benzi, T. M. C. Ogasawara, J. C. Ferreira, L. R. L. Pereira, G. U. L. Braga, C. M. Ribeiro, F. R. Pavan, A. W. Zuardi, J. E. C. Hallak, J. A. d. S. Crippa, , L. N. Andrade

This study evaluates CBD's antibacterial activity and its combination with polymyxin B against multidrug-resistant bacteria, showing synergistic effects against resistant strains.

bioRxiv · Apr 12, 2021 · PreprintMicrobiology